Literature DB >> 2210849

The last round against bacterial infections?

W Marget.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210849     DOI: 10.1007/bf01643384

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  13 in total

Review 1.  Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

Authors:  O Westphal
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin.

Authors:  E T Rietschel; Y B Kim; D W Watson; C Galanos; O Lüderitz; O Westphal
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

3.  [Lipid A antibody titers in pyelonephritis and other gram-negative infections (author's transl)].

Authors:  G Simon; B Reindke; W Marget
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Letter: Lipopolysaccharides in Crohn's disease.

Authors:  W Marget; P Schüssler
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

5.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  [Antibody to lipoid A in the treatment of septic shock].

Authors:  L Jaspers; W Marget; P J Mar; K Hoffmann; P Langecker; G Ruckdeschel; A Obermeier; E Kastenbauer
Journal:  Infection       Date:  1987       Impact factor: 3.553

7.  Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.

Authors:  N N Teng; H S Kaplan; J M Hebert; C Moore; H Douglas; A Wunderlich; A I Braude
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study.

Authors:  P J Mar; W Marget; K Schneider; B H Belohradsky; R Roos
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

9.  Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients.

Authors:  W Marget; P J Mar; L Jaspers; K Possinger; H Haslberger
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

10.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.